Expression of Dopaminergic Receptors on Human CD4+ T Lymphocytes: Flow Cytometric Analysis of Naive and Memory Subsets and Relevance for the Neuroimmunology of Neurodegenerative Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Neuroimmune Pharmacology

• Publication date

  2014-03-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11481-014-9541-5PMID 24682738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?

  2013cited by this paper
• Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson’s Disease

  2013cited by this paper
• Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity

  2013cited by this paper
• CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease

  2012influential reference
• Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity.

  2012cited by this paper
• Nerve-driven immunity : neurotransmitters and neuropeptides in the immune system

  2012cited by this paper
• Dopamine in the Immune System: Dopamine Receptors in Immune Cells, Potent Effects, Endogenous Production and Involvement in Immune and Neuropsychiatric Diseases

  2012cited by this paper
• Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy

  2012cited by this paper
• The Physiology, Signaling, and Pharmacology of Dopamine Receptors

  2011cited by this paper
• Dopamine Induces IL-6–Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model

  2011cited by this paper
• The immunoregulatory role of dopamine: an update.

  2010cited by this paper
• Apoptosis of peripheral blood lymphocytes in Parkinson patients.

  2010cited by this paper
• Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target

  2010cited by this paper
• Dopamine released by dendritic cells polarizes Th2 differentiation.

  2009cited by this paper
• Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease

  2009cited by this paper
• Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis.

  2008cited by this paper
• Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis.

  2008cited by this paper
• Nitrated Alpha-Synuclein and Microglial Neuroregulatory Activities

  2008cited by this paper
• CD4+ T cells from Copolymer-1 immunized mice protect dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

  2007cited by this paper
• Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop.

  2007cited by this paper
• Cutting Edge: Stimulation of Dopamine D4 Receptors Induce T Cell Quiescence by Up-Regulating Krüppel-Like Factor-2 Expression through Inhibition of ERK1/ERK2 Phosphorylation1

  2006cited by this paper
• Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both.

  2005cited by this paper
• Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both

  2005cited by this paper
• Interferon-γ and interferon-β affect endogenous catecholamines in human peripheral blood mononuclear cells: Implications for multiple sclerosis

  2005cited by this paper
• Interferon-gamma and interferon-beta affect endogenous catecholamines in human peripheral blood mononuclear cells: implications for multiple sclerosis.

  2005cited by this paper
• Central memory and effector memory T cell subsets: function, generation, and maintenance.

  2004cited by this paper
• Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect.

  2004cited by this paper
• Phenotypic heterogeneity of antigen‐specific CD4 T cells under different conditions of antigen persistence and antigen load

  2004cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis.

  2002cited by this paper
• Stimulation with phytohaemagglutinin induces the synthesis of catecholamines in human peripheral blood mononuclear cells: role of protein kinase C and contribution of intracellular calcium.

  2002cited by this paper
• Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study.

  2002cited by this paper
• Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates β1 integrin function

  2001cited by this paper
• Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism.

  2001cited by this paper
• Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells.

  2000cited by this paper
• HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines.

  2000cited by this paper
• Dopamine, a neurotransmitter, influences the immune system.

  2000cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Endogenous catecholamine synthesis, metabolism storage, and uptake in human peripheral blood mononuclear cells.

  1999cited by this paper
• Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes.

  1999cited by this paper
• Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils.

  1999cited by this paper
• Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study.

  1999cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Identification of catecholamines in the immune system by electrospray ionization mass spectrometry.

  1998cited by this paper
• Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods.

  1997cited by this paper
• High-affinity binding sites for neuroleptic drugs in human peripheral blood lymphocytes and their relation to dopamine receptors. A long-standing controversy.

  1995cited by this paper
• The immunological status in Parkinson's disease.

  1991cited by this paper

• “Recommendations for clinical study protocols for immune and inflammatory profiling in Parkinson’s disease”

  2025cites this paper
• Single-cell peripheral immunoprofiling of Lewy body and Parkinson’s disease in a multi-site cohort

  2024cites this paper
• DRD1 suppresses cell proliferation and reduces EGFR activation and PD‐L1 expression in NSCLC

  2024cites this paper
• Peripheral immune profile in drug-naïve dementia with Lewy bodies

  2024cites this paper
• The Role of T-lymphocytes in Central Nervous System Diseases.

  2024cites this paper
• The reciprocal interactions between microglia and T cells in Parkinson’s disease: a double-edged sword

  2023cites this paper
• Anti-Inflammatory Effects of Peripheral Dopamine

  2023cites this paper
• Dopamine D2 receptor on CD4+ T cells is protective against inflammatory responses and signs in a mouse model of rheumatoid arthritis

  2023influential citation
• Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease.

  2023cites this paper
• The Dopamine Gene Receptors (DRD1-5) Expression Alteration in Psoriasis Patients.

  2022cites this paper
• DAT and TH expression marks human Parkinson’s disease in peripheral immune cells

  2022cites this paper
• Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights

  2022cites this paper
• Dopaminergic inhibition of human neutrophils is exerted through D1‐like receptors and affected by bacterial infection

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• Effect of quetiapine on inflammation and immunity: a systematic review

  2022cites this paper
• Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cells.

  2021cites this paper
• The role of dopamine receptors in lymphocytes and their changes in schizophrenia

  2021cites this paper
• T Cells Plead for Rejuvenation and Amplification; With the Brain’s Neurotransmitters and Neuropeptides We Can Make It Happen

  2021cites this paper
• Cellular and molecular pathophysiology in the progression of Parkinson’s disease

  2021cites this paper
• Peripheral Immune Cell Numbers and C-Reactive Protein in Parkinson’s Disease: Results from a Population-Based Study

  2021cites this paper
• Dopamine receptor D2 on CD4+ T cells is protective against neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.

  2021cites this paper
• Peripheral Immune Profile and Neutrophil‐to‐Lymphocyte Ratio in Parkinson's Disease

  2021cites this paper
• Control of T-Cell Activation and Signaling by Amino-Acid Catabolizing Enzymes

  2020cites this paper
• Dopaminergic and Adrenergic Pathways as Targets for Drug Repurposing in the Neuroimmune Network

  2020cites this paper
• Pro‐inflammatory dopamine‐2 receptor‐specific T cells in paediatric movement and psychiatric disorders

  2020cites this paper
• Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of Psoriasis patients and inflamed human skin, by D1‐like receptor agonist: Fenoldopam

  2019cites this paper
• Alpha synuclein in hematopoiesis and immunity

  2019cites this paper
• Functional Significance of Endocrine-Immune Interactions in Health and Disease.

  2019cites this paper
• Age-Related Dopaminergic Innervation Augments T Helper 2-Type Allergic Inflammation in the Postnatal Lung.

  2019cites this paper
• Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.

  2019cites this paper
• Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors.

  2019cites this paper
• Cerebral administration of alpha-synuclein monomers modulates inflammatory reaction in nigro-striatal system

  2019cites this paper
• The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor

  2019cites this paper
• Expression of Dopamine Receptors in Immune Regulatory Cells

  2019cites this paper
• Bach2 is a potent repressor of Nrf2-mediated antioxidant enzyme expression in dopaminergic neurons

  2019cites this paper
• The modulatory role of dopamine receptors in brain neuroinflammation.

  2019cites this paper
• Therapeutic Advances in Neurological Disorders

  2018cites this paper
• Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis

  2018cites this paper
• Alteration of Mevalonate Pathway in Rat Splenic Lymphocytes: Possible Role in Cytokines Secretion Regulated by L-Theanine

  2018cites this paper
•  β2‐Adrenoceptors inhibit neutrophil extracellular traps in human polymorphonuclear leukocytes

  2018cites this paper
• [The effect of antipsychotic drug on monoamine receptors in peripheral blood mononuclear cells: affinity linked mechanism].

  2018cites this paper
• Upgraded Methodology for the Development of Early Diagnosis of Parkinson’s Disease Based on Searching Blood Markers in Patients and Experimental Models

  2018cites this paper
• EFFECTS OF ENDOPHYTE-INFECTED TALL FESCUE SEED AND BROMOCRIPTINE ON ENDOCRINE AND IMMUNE FUNCTION IN HORSES

  2018cites this paper
• Dopamine, T cells and multiple sclerosis (MS)

  2017cites this paper
• Dopaminergic Regulation of Innate Immunity: a Review

  2017cites this paper
• Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat

  2017cites this paper
• Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice

  2017cites this paper
• Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease

  2016cites this paper
• Chapter 11 - Dopamine, T Cells, and Multiple Sclerosis: Dopamine Receptors and Direct Effects on T Cells, Dopamine Production in T Cells, Abnormalities in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis, and Their Correction by Treatment

  2016cites this paper
• Diabetic ketoacidosis in patients exposed to antipsychotics: a systematic literature review and analysis of Danish adverse drug event reports

  2016cites this paper
• Possible biomarkers modulating haloperidol efficacy and/or tolerability.

  2016cites this paper
• Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases

  2016influential citation
• Immunomodulatory Effects Mediated by Dopamine

  2016cites this paper
• Leukocyte Responsiveness to Exercise in Individuals Positive for Human Cytomegalovirus

  2016cites this paper
• In vivo effects of methamphetamine on HIV-1 replication: A population-based study.

  2016cites this paper
• The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications

  2016cites this paper
• Pleiotrophin overexpression regulates amphetamine-induced reward and striatal dopaminergic denervation without changing the expression of dopamine D1 and D2 receptors: Implications for neuroinflammation.

  2016cites this paper
• [Dopamine neurotransmission of peripheral blood lymphocytes is a potential biomarker of psychiatric and neurological disorders].

  2015cites this paper
• Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders

  2015cites this paper
• Introduction Citation : McGuinness DH , McGuinness D ( 2014 ) m 6 a RNA Methylation : The Implications for Health and Disease

  2015cites this paper
• Leukocyte Responsiveness to Exercise in HCMV+ Individuals

  2015cites this paper
• Nonmotor symptoms in sporadic versus familial forms of Parkinson's disease.

  2015cites this paper
• Influence of dopamine receptor gene polymorphisms on circulating T lymphocytes: A pilot study in healthy subjects.

  2015cites this paper
• Dopamine Increases CD14+CD16+ Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis

  2015cites this paper
• Dopamine receptor DR2 expression in B cells is negatively correlated with disease activity in rheumatoid arthritis patients.

  2015cites this paper
• m 6 a RNA Methylation: The Implications for Health and Disease

  2014cites this paper
• Contrôle de l'activation microgliale par les lymphocytes T dans un modèle murin de neurodégénérescence induite par la 6-OHDA

  2014cites this paper